Pathologic complete response after neoadjuvant tislelizumab and chemotherapy for Pancoast tumor: A case report
| Autor: | Wen‐Fang Tang, Wei Xu, Wei‐Zhao Huang, Gui‐Nan Lin, Yu‐Mei Zeng, Jie‐Shan Lin, Min Wu, Hua Bao, Jie‐Wen Peng, Hai‐Ming Jiang, Heng‐Qiang Wang, Ying‐Meng Wu, Hong‐Yu Ye, Yi Liang |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Thoracic Cancer, Vol 12, Iss 8, Pp 1256-1259 (2021) |
| Druh dokumentu: | article |
| ISSN: | 1759-7714 1759-7706 |
| DOI: | 10.1111/1759-7714.13910 |
| Popis: | Abstract A 60‐year‐old man was hospitalized because of numbness and weakness in the right upper limb. Magnetic resonance imaging revealed a large mass in the right upper lobe invading the right eighth cervical and first thoracic nerve root. Biopsy pathology confirmed primary lung adenocarcinoma with a clinical stage of cT4N0M0 IIIA, negative for anaplastic lymphoma kinase fusion gene and epidermal growth factor receptor mutations but positive for programmed death ligand 1 (3%). Neoadjuvant tislelizumab and chemotherapy were offered to this patient with Pancoast tumor, and tumor shrinkage of 71% was achieved. After the operation, surgical pathology indicated pathologic complete response (pCR). Circulating tumor cells testing was negative after the first adjuvant treatment. In this case, we provide real‐world evidence of encouraging pCR with neoadjuvant tislelizumab and chemotherapy for a patient with Pancoast tumor. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|